GITEX EUROPE 2025 - Reigniting an Open, Bold & Collaborative European Digital Economy Amidst €200bn AI Ambitions
Innovation, investment and government leaders set to meet at GITEX EUROPE x Ai Everything, 21-23 May, Messe Berlin, the continent’s largest inaugural tech, startup and digital investment event
Berlin, April 15, 2025 - Europe is at a technological turning point: With investments of 200 billion euros in artificial intelligence and a strong focus on quantum technology and cloud data storage, a new era of digital transformation is beginning. From May 21 to 23, 2025, GITEX EUROPE x Ai Everything will be the leading platform for tech innovations, start-ups and investors at the Berlin trade fair for the first time. Against the backdrop of growing international competition, Germany, the world's third-largest economy, plays a central role as Europe's driving force for the next generation of key technologies.
Franziska Giffey, Senator for Economics, Energy and Enterprises and Mayor of Berlin, explains: “Partnering with one of the largest tech and startup global events and hosting the debut of GITEX EUROPE in Berlin strengthens our commitment to solidifying Germany’s position as a global magnet for investment and frontier-pushing technologies, spearheading Europe’s edge in the next digital decade.”
Europe's tech elite is shaping the next generation of key technologies
More than 500 top international speakers discuss strategic decisions - from AI and quantum technology to data security and green tech. Highlights include Geoffrey Hinton, Nobel Laureate in Physics 2024, and many more. Over 1,400 companies from a total of 100 countries will come together, including platinum sponsors AWS and IBM, as well as tech giants such as Cisco, Dell, Nvidia and SAP, to strengthen partnerships and promote innovation that positions Europe as a dynamic and technologically sovereign player.
Trixie LohMirmand, CEO of KAOUN International, explains: “Amid the AI whirlwinds, there is a coordinated consensus and renewed urgency and unity across Europe to assert its digital sovereignty and leadership as a global innovation force. The region is paving its way as a centre-stage where AI, quantum and deep tech supremacy will be debated, developed, and scaled, and GITEX EUROPE strategically hosted in this vantage nexus and watershed time in history shall define Europe’s technological future in an epoch where leadership is earned through bold action and solidarity.”[SN1]
Europe’s Boldest Moves in AI, Deep Tech & Quantum
The conference showcases the full range and international appeal of European AI ecosystems. Ai Everything Europe, the event's central AI forum, brings together thought leaders, start-ups and investors from the field of artificial intelligence. GITEX Quantum Expo (GQX), in partnership with IBM and QuIC - the largest quantum industry association in Europe - drives quantum research through cross-sector collaborations.Press accreditation: click here
Digital Press Kit: click here
Follow GITEX EUROPE on social media:
Facebook | Instagram | X | LinkedIn | Youtube
Hashtag: #GITEXEUROPE
GITEX EUROPE x Ai Everything 2025 - Europe's tech trade fair for the digital future
May 21-23, 2025 | Messe Berlin
GITEX EUROPE is part of the global GITEX network with events in Germany, Morocco, Nigeria, Singapore, Thailand and the UAE. More than 1400 companies, 750 start-ups and SMEs from over 100 countries and 500+ experts are represented at the trade fair. Further information can be found at: www.gitex-europe.com.
mc Group Media Contact:
Elizaveta Shulyndina, Senior Account Manager, mc Group | e.shulyndina@mcgroup.com
Tel.: +49 (0) 30 65 000 459
Mob.: +49 (0) 177 954 60 26
KAOUN International Media Contact:
Tayce Marchesi, PR Manager, DWTC & KAOUN International | tayce.marchesi@dwtc.com
Images
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Biomay Obtains FDA Approval for Manufacturing of Cas9 Nuclease at Headquarters Site29.4.2025 14:00:00 CEST | Press Release
The company announced its successful approval by the U.S. Food and Drug Administration (FDA) for the manufacturing, testing and release of recombinant Cas9 nuclease from its headquarters site. Cas9 is an essential component of CRISPR-based gene editing therapies, including CASGEVY® (exagamglogene autotemcel) developed and launched by Vertex Pharmaceuticals. Biomay's recent achievement refers to an inspection by the FDA's Center for Biologics Evaluation and Research (CBER) at Biomay's headquarters manufacturing site in Vienna, Seestadt in December 2024. No observation was found, and no Form FDA 483 was issued by the authority, allowing Biomay's headquarters site to supply Cas9 for the United States. Biomay operates two independent cGMP manufacturing sites, a headquarters facility in Vienna Seestadt, and a second site in Vienna downtown. The authority’s approval of Biomay's headquarters site represents the company's second successful FDA inspection following the 2023 approval of Biomay's
Growth and innovation as cornerstones of a strong democracy and a digitally sovereign Europe29.4.2025 12:00:00 CEST | Pressmeddelande
Germany should be restored to a growth path and should give new impulse to innovation, along with its European partners. Because prosperity is a significant guarantor of a stable democracy. Digital sovereignty is the anchor of a strong Europe. Germany can once again be a country of pioneering innovation and a pacesetter for the continent. For this, comprehensive modernization of the state is indispensable. The Bertelsmann Stiftung presented its proposals at the annual press conference.
Acousia Therapeutics Reaches 50% Patient Enrollment Milestone in Phase 2 PROHEAR Study29.4.2025 09:00:00 CEST | Press Release
Tübingen, Germany, April 29, 2025 Acousia Therapeutics GmbH announced that it has successfully enrolled 50% of patients in its ongoing Phase 2 clinical trial, the PROHEAR Study, evaluating ACOU085 (INN: bimokalner) for the prevention of cisplatin-induced hearing loss in patients with testicular cancer undergoing chemotherapy.
Australia’s next government must mend structural cracks appearing in its political, economic and social foundation, report finds25.4.2025 12:05:00 CEST | Pressmeddelande
- Picture is available at AP - Los Angeles/DNA - Australia boasts some of the world’s most sophisticated political institutions and one of its wealthiest economies. But this veneer of success masks deeper structural issues — and a “ticking time bomb” of overreliance on extractive industries must be addressed under Australia’s next government, a new report recommends.
DYMO® LETRATAG 200B VINNER DET PRESTIGEFYLLDA PRISET ”BUSINESS PRODUCT OF THE YEAR” - STRUKTURERAR OCH ORGANISERAR VARDAGEN24.4.2025 16:44:06 CEST | Press Release
Amsterdam – vikten av organisering, effektivitet och produktivitet i både personliga och professionella sammanhang har aldrig varit större. Detta då allt fler använder smarta lösningar för att förenkla sin vardag. DYMO®, en ledande leverantör av innovativa etikett- och utskriftslösningar, ligger här i framkant. Som ett erkännande har DYMO LetraTag 200B belönats med EOPA Best Business Product Award, en utmärkelse som lyfter fram hur den förenklat organisering både hemma och på kontoret. "Trenden mot smart självorganisering fortsätter", berättar Liesbet De Soomer, Global Marketing Director på DYMO. "LetraTag 200B stödjer utveckligen genom att erbjuda en användarvänlig lösning, som gör märkningen snabb och enkel. Med det här verktyget kan användaren strukturera vardagskaoset och organisera tillvaron.” EOPA Best Business Product Award, som delas ut årligen, uppmärksammar produkter som sticker ut för sitt nytänkande, sin funktionalitet och sin användarvänlighet. LetraTag 200B:s utmärkelse b
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom